Cardiovascular Health Mission
The Cardiovascular Health Mission will invest $220 million over 10 years to bring together researchers, health professionals, industry and patients to make transformative improvements in heart and vascular health and stroke for all Australians.
What is the Cardiovascular Health Mission?
The Cardiovascular Health Mission is a $220 million research fund that will support a large program of work over 10 years to improve heart health and reduce stroke in Australia.
The term ‘cardiovascular disease’ includes many different conditions affecting the heart and blood vessels. The most common and serious types of cardiovascular disease are:
- coronary heart disease
- stroke
- heart failure
Why is the Cardiovascular Health Mission important?
Cardiovascular disease has a big impact on Australians.
- Coronary heart disease is the leading cause of death in Australia – causing 12% of all deaths (43% of cardiovascular disease deaths).
- Stroke causes around 5% of all deaths (19% of deaths due to cardiovascular disease).
- Cardiovascular disease accounted for almost 14% of the total burden of disease in 2015.
- Our health system spent $10.4 billion on cardiovascular diseases in 2015–16.
What are the goals of the Cardiovascular Health Mission?
The Cardiovascular Health Mission’s goal is to make transformative improvements in cardiovascular health and stroke for all Australians.
How will we meet these goals?
The mission will:
- accelerate Australian-led research to advance cardiovascular health
- create a world-class research environment that serves the health system
See the mission snapshot for details of how we plan to meet these goals.
MRFF snapshot – Cardiovascular Health Mission
This snapshot shows this mission at a glance. It includes budgets, early funding priorities and grant timelines, as at November 2019. Researchers and other stakeholders can use it to plan for upcoming opportunities and see how the mission will be established, expanded and embedded over time.
Who works with us on the Cardiovascular Health Mission?
The Cardiovascular Health Mission Expert Advisory Panel provides advice on priorities for research investment through the mission by developing a Roadmap and Implementation Plan. Public consultation on the Roadmap and Implementation Plan opened on 14 December 2020 and will close on 23 April 2021. Submissions through the consultation will be used to inform any further development of the Roadmap and Implementation Plan by the Expert Advisory Panel.
The Medical Research Future Fund (MRFF) funds the mission.
Our Health and Medical Research Office oversees this and other MRFF initiatives.
The National Health and Medical Research Council (NHMRC) administers this mission.
Apply for funding
We will list grants on GrantConnect when they open. If you want GrantConnect to notify you about future MRFF grants:
- register with them
- enter ‘MRFF’ in the keyword section of your GrantConnect profile
Status
Upcoming grants
There are currently no upcoming grant opportunities.
Open grant rounds
The 2020 Cardiovascular Health grant opportunity opened on 16 December 2020 and will close on 3 March 2021.
Grants being assessed
No grant rounds are currently being assessed.
Grants awarded
We have awarded the following grants under this initiative, as at 30 October 2020.
|
Funded Institution |
Project Name |
Chief Investigator/s |
Total Funding |
|
Queensland University of Technology |
CHD LIFE+ family-centred care models supporting long-term neurodevelopment |
Professor Steven McPhail |
$2,997,256 |
|
The University of Adelaide |
Maternal exposures, congenital heart defects, and child development |
Professor Michael Davies |
$3,037,417 |
|
The University of Queensland |
Gene Expression to Predict Long-Term Outcome in Infants After Heart Surgery |
Associate Professor Luregn Schlapbach |
$3,068,742 |
|
University of Sydney |
An Australian Study of the Outcomes and Burden of Congenital Heart Disease |
Professor David Selermajer |
$3,994,175 |
|
University of Sydney |
Congenital Heart Fitness Intervention Trial: CH-FIT |
Doctor Rachel Cordina |
$3,328,569 |
|
University of Sydney |
Personalised Pulmonary Valved Conduits: reducing re-operations in CHD |
Professor Fariba Dehghani |
$2,081,761 |
|
National Heart Foundation of Australia |
2020 Strategic Research Grants |
Not applicable |
$4,000,000 |
|
National Stroke Foundation |
The Australian Paediatric Acute Code Stroke (PACS) study |
Not applicable |
$4,000,000 |
|
Monash University |
Using Polygenic Risk Scores to Target Statin Therapy in Primary Prevention |
Professor Stephen Nicholls |
$1,416,095 |
|
University of Melbourne |
A randomised controlled trial of ultra-early, minimally invasive surgery for intracerebral haemorrhage (EVACUATE) |
Professor Bruce Campbell |
$2,138,226 |
|
University of New South Wales |
Novel deep learning methods for large-scale cardiovascular risk screening using Australian digital health data |
Professor Louisa Jorm |
$1,467,091 |
|
University of New South Wales |
Total Cardiac Care - STROKE: A randomised controlled trial of a comprehensive smartphone application-centric model of care to improve outcomes in stroke patients |
Professor Ken Butcher |
$1,629,905 |
|
University of New South Wales |
The SaltSwitch Online Grocery Shopping (OGS) Trial: A Novel Method for Reducing Blood Pressure among Individuals with Hypertension |
Associate Professor Jason Wu |
$1,687,990 |
|
University of Sydney |
Colchicine After Stroke to Prevent Event Recurrence (CASPER) Study |
Professor Anthony Keech |
$2,997,908 |
|
Total |
$37,845,135 |
||
We publish the details of all MRFF grants we have approved after they have been tabled at budget estimates, supplementary budget estimates or additional estimates. This means there is a delay between us approving grants and the details appearing here.
Related information
See a list of all MRFF grant recipients.
Contact
For more information contact us.
Medical Research Future Fund (MRFF) contact
Contact for more information about the Medical Research Future Fund (MRFF), or to provide feedback on the MRFF website.
National Health and Medical Research Council (NHMRC)
The National Health and Medical Research Council (NHMRC) funds high quality health and medical research to build research capability, support researchers, encourage the translation of research into better health outcomes and promote the highest ethical standards for health and medical research.